164 results
Page 6 of 9
F-3
qeo7c2699f
7 Aug 19
Shelf registration (foreign)
12:00am
POS AM
5tjlqk
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
EX-99.1
gdzdj8qn7xiqx2
4 Jun 19
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
8hmty9r
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
2f413
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
69qa 8alt8
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
8f4z0c
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
ms1sfldq y84nd
20 Dec 18
Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia
8:01am
6-K
EX-99.1
2h3plw 2z7ubotwnpx4
14 Nov 18
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
8:05am
6-K
EX-99.1
2r0lra 26o9a
14 Nov 18
Current report (foreign)
7:00am
POS AM
f83k8idov3nyp8i2n
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
424B5
otkp2s
5 Oct 18
Prospectus supplement for primary offering
12:00am
424B5
69bt 3n9kw
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
botgt0rh
14 Aug 18
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2019
1:04pm
6-K
EX-99.1
kk603wz
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.1
hp6306m5o1jg
27 Jun 18
Current report (foreign)
5:27pm
6-K
EX-99.1
mblwad7 akj
27 Jun 18
Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018
5:01pm